login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ATAI LIFE SCIENCES NV (ATAI) Stock News
USA
- NASDAQ:ATAI -
NL0015000DX5
-
Common Stock
5.23
USD
+0.09 (+1.75%)
Last: 10/3/2025, 8:23:34 PM
5.2498
USD
+0.02 (+0.38%)
After Hours:
10/3/2025, 8:23:34 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ATAI Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Benzinga
- Mentions:
NVDA
LAC
BABA
UUUU
...
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
12 days ago - By: Benzinga
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews
12 days ago - By: The Motley Fool
Why Atai Life Sciences Stock Crushed It on Tuesday
13 days ago - By: atai Life Sciences
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
3 months ago - By: atai Life Sciences
atai Life Sciences Announces $50 Million Private Placement Financing
13 days ago - By: atai Life Sciences
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
18 days ago - By: atai Life Sciences
atai Life Sciences Awarded Grant from the National Institutes of Health
18 days ago - By: atai Life Sciences
atai Life Sciences Awarded Grant from the National Institutes of Health
a month ago - By: Zacks Investment Research
- Mentions:
HALO
Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year?
a month ago - By: atai Life Sciences
atai Life Sciences to Participate in September Investor Conferences
a month ago - By: atai Life Sciences
atai Life Sciences to Participate in September Investor Conferences
2 months ago - By: Zacks Investment Research
Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now
2 months ago - By: The Motley Fool
Atai Life Sciences Revenue Jumps 163%
2 months ago - By: atai Life Sciences
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
2 months ago - By: atai Life Sciences
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
2 months ago - By: Yahoo Finance
H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10
2 months ago - By: atai Life Sciences
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
2 months ago - By: atai Life Sciences
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
3 months ago - By: Yahoo Finance
Aegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 Target
3 months ago - By: Yahoo Finance
- Mentions:
GS
Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)’s Price Target To $12, Maintains Buy Rating
3 months ago - By: FN Media Group LLC
- Mentions:
NYSE
CMPS
SAGE
MNMD
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
3 months ago - By: atai Life Sciences
atai Life Sciences Announces $50 Million Private Placement Financing
Please enable JavaScript to continue using this application.